Brief: Brain Biotech Says Issuance Of EUR 5 Mln Convertible Bond With Exclusion Of Subscription Rights
29/02/2024 19:07
Feb 29 (Reuters) - BRAIN Biotech AG BNNn.DE :
* EQS-ADHOC: BRAIN BIOTECH AG: ISSUANCE OF EUR 5 MILLION
CONVERTIBLE BOND WITH EXCLUSION OF SUBSCRIPTION RIGHTS
* CONVERTIBLE BONDS WITH A DENOMINATION OF EUR 1,000 EACH
WILL BE
ISSUED PRESUMABLY ON 5 MARCH 2024 AT 100% OF NOMINAL AMOUNT
* CONVERTIBLE BONDS WILL BEAR INTEREST AT A RATE OF 6.52%
P.A. ON
NOMINAL AMOUNT.
Source text for Eikon: ID:nEQ5lC8v6a
Further company coverage: BNNn.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BRAIN Biotech AG
See all newsBrief: BRAIN Biotech 9M EBITDA EUR -1.6 Million
CEOs Lukas Linnig And Michael Krohn To Leave Co
Brief: Brain Biotech Signs Exclusive Pharma Licensing Agreement With Akribion For Up To EUR 92.3 Million Milestone Fees Plus Royalties
Brief: BRAIN Biotech 9M Adj. EBITDA at EUR -1.2 Million
Europe Research Roundup: AB Foods, Bunzl, Barratt